Cutaneous Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Cutaneous Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients [NA]
This document describes a clinical study protocol evaluating alpha-radiation therapy for cutaneous squamous cell carcinoma in immunocompromi…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma [NA]
A clinical trial is evaluating Alpha DaRT224 for recurrent cutaneous squamous cell carcinoma, focusing on efficacy and safety. The study is …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Expanded Access Use of Cemiplimab in Patients With Solid Tumors
Expanded access update on cemiplimab for patients with solid tumors, including non-small cell lung cancer, basal cell carcinoma, and cutaneo…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating SOT101 in combination with pembrolizumab in selected advanced solid tumors was terminated; results have been posted…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: High-Risk Skin Cancers With Atezolizumab Plus NT-I7 [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluating the combination of atezolizumab and NT-I7 for high-risk skin cancers (melanoma, Merkel cell carcinom…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial of INCB099318 in participants with advanced solid tumors has been terminated. The update reports safety, tolerability…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of the monoclonal antibody IMT-009 in various advanced solid tumors and lymphomas, with t…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: CemiplimAb Survivorship Epidemiology
Completed clinical trial studying survivorship epidemiology for cemiplimab in skin cancers, including cutaneous squamous cell carcinoma and …
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision [EARLY_Phase 1]
This early-phase clinical trial is evaluating intratumoral administration of a seasonal influenza vaccine in patients with cutaneous squamou…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Personalised Immunotherapy Platform
Clinical trial update for a personalised immunotherapy platform; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.
Clinical trial investigating immune profiles, treatment response, and toxicity markers in skin cancer patients treated with cemiplimab using…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin) [Phase 3]
This entry reports a Phase 3 clinical trial (SiroSkin) evaluating topical sirolimus for chemoprevention of facial cutaneous squamous cell ca…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors [Phase 1]
Phase 1 study of MEM-288 oncolytic virus in advanced solid tumors, evaluating MEM-288 alone and in combination with standard-of-care therapy…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating safety and tolerability of BCA101 as monotherapy and in combination in EGFR-driven advanced solid tumors. The trial…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer [Phase 1]
Phase 1 trial of cemiplimab (Libtayo) given before and after surgery for high-risk cutaneous squamous cell carcinoma is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating neoadjuvant nivolumab, with or without ipilimumab, in patien…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of radiation therapy and cemiplimab for cutaneous squamous cell carcinoma, including local…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma [Phase 1]
Phase 1 study investigating Tolododekin Alfa (ANK-101) in renal allograft recipients with high-risk cutaneous squamous cell carcinoma, statu…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630) [Phase 3]
A Phase 3 trial (MK-3475-630/KEYNOTE-630) evaluating pembrolizumab versus placebo after surgery and radiation in locally advanced cutaneous …
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial reports on the safety, tolerability, pharmacokinetics, and pharmacodynamics of INCB099280 in participants with advanced s…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders [Phase 2]
A Phase 2 clinical trial at Oslo University Hospital is testing fecal microbiota transplantation from clinical responders in cancer patients…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy [Phase 2]
Phase 2 study of Avelumab with radical radiotherapy in unresectable cutaneous squamous cell carcinoma was terminated.
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors [Phase 1, Phase 2]
Open-label Phase 1/2 trial evaluating ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy for EGFR-expressing advanced solid tu…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck [NA]
A study assessing sentinel lymph node biopsy for cutaneous squamous cell carcinoma of the head and neck is currently recruiting, with Indian…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer [Phase 2]
Phase 2 clinical trial update evaluating Mohs micrographic surgery followed by short-course radiation therapy with structured follow-up for …